
Commentary|Articles|August 26, 2026
Beyond the itch: Recognizing vision-threatening eye allergy in children
Author(s)Kassi Filkins, Angela Zhu, MD
Angela Y. Zhu, MD, of Bascom Palmer Eye Institute, explains how to distinguish eye allergy from vision-threatening VKC and AKC in children and when steroid-sparing therapy and referral are warranted.
Advertisement
Advertisement
Children's Eye Health and Safety Month centers largely on vision screening and injury prevention, but allergic eye disease is a quietly common—and sometimes vision-threatening—part of pediatric eye care. Seasonal and perennial allergic conjunctivitis affect a large share of children, while more severe forms such as vernal keratoconjunctivitis (VKC) and atopic keratoconjunctivitis (AKC) can progress to shield ulcers, corneal scarring, and lasting visual compromise if missed.
Related to this article

Luma, an eye-tracking and assessment tool, helps eye care professionals gain objective insights into visual performance.

Anat Galor, MD, MSPH, discusses subtyping dry eye, emerging diagnostic tools, and when to consider oral neuromodulation.

Lambert-Eaton myasthenic syndrome is a rare autoimmune disorder of the neuromuscular junction that should be differentiated from myasthenia gravis, another neuromuscular junction disorder.

Phase 3 SLO-RP Preserve will test whether oral NPI-001 slows photoreceptor loss in retinitis pigmentosa due to Usher syndrome.

FDA grants orphan drug designation to oral OCT-980 for RHO-adRP, now in phase 1b/2 testing at US sites.

Johnson & Johnson spotlights contrast-driven cataract outcomes at AAO 2026, touting TECNIS PureSee/Odyssey data, 1M implants, and SmartLOAD injector sustainability.

Patients with atrial fibrillation (AF) had measurable structural retinal changes in a large international study.
Advertisement
Advertisement

